...
首页> 外文期刊>American Journal of Physiology >On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells
【24h】

On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells

机译:ATP释放,ectoATPase活性和细胞外ADP在Huh-7人肝癌细胞调节体积减少中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hypotonicity triggered in human hepatoma cells (Huh-7) the release of ATP and cell swelling, followed by volume regulatory decrease (RVD). We analyzed how the interaction between those processes modulates cell volume. Cells exposed to hypotonic medium swelled 1.5 times their basal volume. Swelling was followed by 41% RVD40 (extent of RVD after 40 min of maximum), whereas the concentration of extracellular ATP (ATPe) increased 10 times to a maximum value at 15 min. Exogenous apyrase (which removes di-and trinucleotides) did not alter RVD, whereas exogenous Na+-K+-ATPase (which converts ATP to ADP in the extracellular medium) enhanced RVD40 by 2.6 times, suggesting that hypotonic treatment alone produced a basal RVD, whereas extracellular ADP activated RVD to achieve complete volume regulation (i.e., RVD40 ≈100%). Under hypotonicity, addition of 2-(methylthio)adenosine 5'-diphosphate (2MetSADP; ADP analog) increased RVD to the same extent as exposure to Na+-K+-ATPase and the same analog did not stimulate RVD when coincubated with MRS2211, a blocker of ADP receptor P2Y13. RT-PCR and Western blot analysis confirmed the presence of P2Y13. Cells exhibited significant ectoATPase activity, which according to RT-PCR analysis can be assigned to ENTPDase2. Both carbenoxolone, a blocker of conductive ATP release, and brefeldin A, an inhibitor of exocytosis, were able to partially decrease ATPe accumulation, pointing to the presence of at least two mechanisms for ATP release. Thus, in Huh-7 cells, hypotonic treatment triggered the release of ATP. Conversion of ATPe to ADPe by ENTPDase 2 activity facilitates the accumulated ADPe to activate P2Y13 receptors, which mediate complete RVD.
机译:低渗性触发人肝癌细胞(Huh-7)释放ATP和细胞肿胀,随后体积调节降低(RVD)。我们分析了这些过程之间的相互作用如何调节细胞体积。暴露于低渗培养基的细胞膨胀了其基础体积的1.5倍。溶胀之后是41%RVD40(最大40分钟后RVD的程度),而细胞外ATP(ATPe)的浓度增加了10倍,达到15分钟时的最大值。外源性腺苷三磷酸脱氢酶(去除二核苷酸和三核苷酸)不会改变RVD,而外源性Na + -K + -ATPase(在细胞外培养基中将ATP转化为ADP)使RVD40增强2.6倍,这表明低渗治疗仅产生了基础RVD。细胞外ADP激活RVD以实现完全的体积调节(即RVD40≈100%)。在低渗状态下,添加2-(甲硫基)腺苷5'-二磷酸(2MetSADP; ADP类似物)与暴露于Na + -K + -ATPase的程度相比,RVD升高的程度相同;当与阻断剂MRS2211共孵育时,相同的类似物不会刺激RVD ADP受体P2Y13的表达。 RT-PCR和蛋白质印迹分析证实了P2Y13的存在。细胞表现出显着的ectoATPase活性,根据RT-PCR分析可以将其分配给ENTPDase2。羧甲基环孕酮(传导性ATP释放的阻滞剂)和布雷菲德菌素A(胞吐作用的抑制剂)都能够部分减少ATPe的积累,表明存在至少两种ATP释放机制。因此,在Huh-7细胞中,低渗处理触发了ATP的释放。 ENTPDase 2活性将ATPe转化为ADPe有助于积累的ADPe激活P2Y13受体,后者介导完整的RVD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号